Overview

Angiotensin 1-7 in Obesity Hypertension

Status:
Recruiting

Trial end date:
2023-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to find out if the investigational drug angiotensin-(1-7) improves cardiovascular health in patients with obesity and high blood pressure.

Phase:

Early Phase 1

Details

Lead Sponsor:

Amy Arnold

Collaborator:

American Heart Association

Treatments:

Angiotensin I (1-7)